iBio (IBIO) Share-based Compensation (2010 - 2026)

iBio (IBIO) has 17 years of Share-based Compensation data on file, last reported at $377000.0 in Q1 2026.

• On a quarterly basis, Share-based Compensation rose 1.89% year-over-year to $377000.0 in Q1 2026; TTM through Mar 2026 was $1.2 million, a 24.88% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, up 30.42% from the prior year.
• Share-based Compensation for Q1 2026 stood at $377000.0, up from $253000.0 in the prior quarter.
• Over the last five years, Share-based Compensation for IBIO reached as high as $1.2 million in Q1 2022 and fell as low as -$1.1 million in Q2 2023.
• Historically, Share-based Compensation has averaged $465941.2 across 5 years, with a median of $454000.0 in 2023.
• Across the five-year window, Share-based Compensation surged 224.33% in 2022 and sank 242.37% in 2023, its largest moves.
• Year by year, Share-based Compensation stood at $915000.0 in 2022, then sank by 50.38% to $454000.0 in 2023, then climbed by 4.63% to $475000.0 in 2024, then sank by 46.74% to $253000.0 in 2025, then jumped by 49.01% to $377000.0 in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $377000.0 in Q1 2026, $253000.0 in Q4 2025, and $323000.0 in Q3 2025.